Endocrine Society GUIDELINES Bundle (free trial)

Hyperglycemia

Endocrine Society GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1483748

Contents of this Issue

Navigation

Page 7 of 9

8 Recommendation 7.1 ➤ In most adult patients with hyperglycemia (with or without known type 2 diabetes [T2D]) hospitalized for a non-critical illness, we suggest that scheduled insulin therapy be used instead of non-insulin therapies for glycemic management. (2|⊕⊕ ) Remarks: ▶ Dipeptidyl peptidase-4 inhibitors (DPP4is) may be appropriate in select patients with T2D (see Recommendation 7.2), including those with established non-insulin– requiring diabetes nearing hospital discharge. ▶ It may be reasonable to begin other non-insulin therapies in stable patients prior to discharge as a part of a coordinated transition plan. Recommendation 7.2 ➤ In select adult patients with mild hyperglycemia and T2D hospitalized for a non-critical illness, we suggest using either DPP4i with correction insulin or scheduled insulin therapy. (2|⊕⊕ ) Remarks: ▶ Select patients include those with T2D that is moderately well-managed as reflected by a recent HbA1c <7.5% (9.4 mmol/L); BG <180 mg/dL (10 mmol/L); and, if on insulin therapy before hospitalization, to have a total daily insulin dose <0.6 units/kg/day; this recommendation applies both to patients taking the DPP4i before admission and those who are not. ▶ Patients who develop persistently elevated BG (e.g., >180 mg/dL [10 mmol/L]) on DPP4i therapy should be managed with scheduled insulin therapy; this recommendation does not apply to patients with T1D or other forms of insulin- dependent diabetes. ▶ As with all new therapies started in the hospital, a discussion with the patient about cost and overall acceptability is suggested if there are plans to continue the medication after discharge. Recommendation 8.1 ➤ In adult patients with type 1 diabetes (T1D), T2D, and other forms of diabetes undergoing surgical procedures, we suggest not administering CHO-containing oral fluids preoperatively. (2|⊕ ) Recommendation 9.1 ➤ In adult patients with non-insulin treated T2D hospitalized for non- critical illness who require prandial insulin therapy, we suggest not CC for calculating prandial insulin doses. (2|⊕ ) Recommendation 9.2 ➤ In adult patients with T1D, insulin-treated T2D hospitalized for non- critical illness, we suggest either CC or no CC with fixed prandial insulin dosing. (2|⊕ ) Treatment

Articles in this issue

Archives of this issue

view archives of Endocrine Society GUIDELINES Bundle (free trial) - Hyperglycemia